Spero Therapeutics
Price & Volume
Stats
See more52W Range | $1.80-$3.22 |
Market Cap | $130.8M |
Shares Short | 1M |
Financials
See moreRevenue (12 Mos) | $61.1M |
Revenue Growth (YoY) | -95.6% |
Gross Profit (12 Mos) | $33.4M |
Diluted EPS | $0.27 |
News
See moreYahoo Finance • 9 days ago
Weekly Buzz: SPRO, ABBV Get FDA Nod, NMRA Halts KOASTAL; ENGN Cuts Jobs; BIIB Acquires RayThera
Yahoo Finance • 10 days ago
Spero: FDA Approves Utebzi, The First Oral Carbapenem For Complicated UTIs In Adults; Stock Up
Yahoo Finance • 3 months ago
Spero Therapeutics Non-GAAP EPS of $0.53, revenue of $41.3M
About
CEO | Ms. Esther P. Rajavelu |
CFO | Ms. Esther P. Rajavelu |
Address | 675 Massachusetts Avenue, Cambridge, MA, United States, 02139 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 25 |